Moving the HME Industry Forward

General Healthcare

Healthy Market Predictions for Home Health

November 25, 2017

According to RnR Market Research, the home healthcare market is predicted to reach $ 364.69 billion by 2022, up from $239.30 billion in 2017, at a compound annual growth rate of 8.8%. Researchers write that: “Growth in this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare. However, changing reimbursement policies, limited insurance coverage, and patient safety concerns are some factors that may hinder the growth of this market.”

Additional report highlights…

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. Factors such as rising geriatric population, increasing adoption of innovative techniques, increasing disposable income, expansion of home healthcare companies in the Asian region, rising awareness of home healthcare, and increasing need for affordable healthcare delivery systems are driving market growth in Asia.

The major market players in the Home Healthcare market are Fresenius (Germany), GE Healthcare (US), Linde Group (Germany), McKesson Corporation (US), Roche (Switzerland), A&D Company (Japan), BAYADA Home Health Care (US), Almost Family (US), Abbott Laboratories (US), Amedisys (US), Kindred Healthcare (US), Kinnser Software (US), LHC Group (US), Omron Healthcare (Japan), Philips Healthcare (Netherlands).

Click the following link to see more of the report.